Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-005908
Filing Date
2025-03-03
Accepted
2025-03-03 16:02:11
Documents
81
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tgtx20241231_10k.htm   iXBRL 10-K 2297248
2 EXHIBIT 21.1 ex_702317.htm EX-21.1 3635
3 EXHIBIT 23.1 ex_702318.htm EX-23.1 2382
4 EXHIBIT 31.1 ex_702319.htm EX-31.1 12338
5 EXHIBIT 31.2 ex_702320.htm EX-31.2 12679
6 EXHIBIT 32.1 ex_702321.htm EX-32.1 5687
7 EXHIBIT 32.2 ex_702322.htm EX-32.2 6034
13 stockgraph.jpg GRAPHIC 58505
  Complete submission text file 0001437749-25-005908.txt   9508493

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20241231.xsd EX-101.SCH 67809
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20241231_cal.xml EX-101.CAL 53694
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20241231_def.xml EX-101.DEF 486632
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20241231_lab.xml EX-101.LAB 460128
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20241231_pre.xml EX-101.PRE 522796
84 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20241231_10k_htm.xml XML 1439951
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 25697659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)